BAM
Byrne Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-613
| Closed | -$305K | – | 115 |
|
|
2025
Q1 | $305K | Sell |
613
-30
| -5% | -$14.9K | 0.23% | 86 |
|
|
2024
Q4 | $335K | Sell |
643
-20
| -3% | -$10.4K | 0.24% | 79 |
|
|
2024
Q3 | $410K | Buy |
+663
| New | +$410K | 0.28% | 77 |
|
|
2024
Q2 | – | Sell |
-728
| Closed | -$423K | – | 82 |
|
|
2024
Q1 | $423K | Sell |
728
-25
| -3% | -$14.5K | 0.29% | 79 |
|
|
2023
Q4 | $400K | Sell |
753
-65
| -8% | -$34.6K | 0.3% | 79 |
|
|
2023
Q3 | $414K | Sell |
818
-65
| -7% | -$32.9K | 0.34% | 72 |
|
|
2023
Q2 | $461K | Sell |
883
-2
| -0.2% | -$1.04K | 0.3% | 95 |
|
|
2023
Q1 | $510K | Sell |
885
-72
| -8% | -$41.5K | 0.36% | 85 |
|
|
2022
Q4 | $527K | Sell |
957
-149
| -13% | -$82.1K | 0.38% | 83 |
|
|
2022
Q3 | $561K | Sell |
1,106
-4
| -0.4% | -$2.03K | 0.43% | 79 |
|
|
2022
Q2 | $603K | Sell |
1,110
-282
| -20% | -$153K | 0.45% | 66 |
|
|
2022
Q1 | $822K | Buy |
1,392
+255
| +22% | +$151K | 0.51% | 63 |
|
|
2021
Q4 | $759K | Buy |
+1,137
| New | +$759K | 0.49% | 61 |
|